Evidence map›Paper›PMID 18443126›Full record

ArticleAntimicrobial agents and chemotherapy2008

Synergy of human immunodeficiency virus protease inhibitors with chloroquine against Plasmodium falciparum in vitro and Plasmodium chabaudi in vivo.

Zhengxiang He, Li Qin, Lili Chen, Nanzheng Peng, Jianlan You, Xiaoping Chen

Open access · greenAbstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
4.1field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 29 citations in OpenAlex.

  1. Trial
  2. The risk of QTc-interval prolongation in COVID-19 patients treated with chloroquine.Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation · 2020
    Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Chloroquine-containing compounds: a patent review (2010 - 2014).Expert opinion on therapeutic patents · 2015
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. HIV proteinase inhibitors target the Ddi1-like protein of Leishmania parasites.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2011
    Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Zhengxiang HeGuangzhou Institute of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, 510663, China.
Li Qin
Lili Chen
Nanzheng Peng
Jianlan You
Xiaoping Chen
Chinese Academy of Sciences · CNGuangzhou Institutes of Biomedicine and Health · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The synergy of the activities between chloroquine and various human immunodeficiency virus protease inhibitors was investigated in chloroquine-resistant and -sensitive malaria parasites. In both in vitro and in vivo assay systems, ritonavir was found to be the most potent in potentiating the antimalarial action of chloroquine.

Indexed as

AnimalsAntimalarialsAtazanavir SulfateChloroquineDrug ResistanceDrug SynergismFemaleHIV Protease InhibitorsHumansIn Vitro TechniquesLopinavirMalariaMiceNelfinavirOligopeptidesPlasmodium chabaudiAntimalarialsAtazanavir SulfateChloroquineHIV Protease InhibitorsLopinavirNelfinavirOligopeptidesPyridinesPyrimidinonesRitonavirSaquinavir

Identifiers

PMID18443126
PMCPMC2443913
OpenAlexW2142088978

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.